Current and developing methods of patient-controlled analgesia.

Area of Science:

• Anesthesiology
• Pharmacology
• Pain Management

Background:

• Opioids via programmable intravenous (IV) patient-controlled analgesia (PCA) infusion pumps are standard for moderate-to-severe acute postoperative pain.
• IV PCA offers patient control, potentially improving satisfaction and pain relief compared to nurse-administered methods.
• Common opioids cause adverse effects, and IV PCA has risks like programming errors, device malfunctions, and infection transmission.

Purpose of the Study:

• To review the current landscape of postoperative pain management using IV PCA.
• To highlight the limitations and adverse effects associated with traditional IV opioid PCA.
• To explore the potential of advanced PCA modalities for improved postoperative pain control.

Main Methods:

• Literature review of existing studies on IV PCA for postoperative pain.
• Analysis of the advantages and disadvantages of current opioid analgesics and administration routes.
• Examination of emerging PCA technologies and alternative administration methods.

Main Results:

• IV PCA provides effective pain relief and patient satisfaction but is associated with significant adverse effects and technical complications.
• The rapid peak and decline of IV opioid concentrations can lead to respiratory depression, sedation, and inadequate pain management.
• Complex pump assembly and potential for errors complicate the use of current IV PCA systems.

Conclusions:

• Novel PCA approaches utilizing advanced opioid analgesics like sufentanil show promise.
• Exploring noninvasive administration routes for PCA could significantly enhance the postoperative pain management experience.
• Future research should focus on developing safer, more effective, and user-friendly PCA systems.